Pacira BioSciences, Inc. (PCRX)
NASDAQ: PCRX · IEX Real-Time Price · USD
26.95
+0.70 (2.67%)
May 1, 2024, 4:00 PM EDT - Market closed
Pacira BioSciences Employees
Pacira BioSciences had 712 employees on December 31, 2023. The number of employees decreased by 3 or -0.42% compared to the previous year.
Employees
712
Change (1Y)
-3
Growth (1Y)
-0.42%
Revenue / Employee
$948,003
Profits / Employee
$58,926
Market Cap
1.25B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 712 | -3 | -0.42% |
Dec 31, 2022 | 715 | 18 | 2.58% |
Dec 31, 2021 | 697 | 73 | 11.70% |
Dec 31, 2020 | 624 | 18 | 2.97% |
Dec 31, 2019 | 606 | 88 | 16.99% |
Dec 31, 2018 | 518 | 29 | 5.93% |
Dec 31, 2017 | 489 | -14 | -2.78% |
Dec 31, 2016 | 503 | 16 | 3.29% |
Dec 31, 2015 | 487 | 40 | 8.95% |
Dec 31, 2014 | 447 | 137 | 44.19% |
Dec 31, 2013 | 310 | 154 | 98.72% |
Dec 31, 2012 | 156 | 23 | 17.29% |
Dec 31, 2011 | 133 | 50 | 60.24% |
Dec 31, 2010 | 83 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Omnicell | 3,650 |
Phreesia | 1,438 |
Ironwood Pharmaceuticals | 267 |
Mirum Pharmaceuticals | 264 |
Scholar Rock Holding | 150 |
4D Molecular Therapeutics | 147 |
Verona Pharma | 79 |
Belite Bio | 20 |
PCRX News
- 1 day ago - Pacira to Report First Quarter 2024 Financial Results on Tuesday May 7, 2024 - GlobeNewsWire
- 4 weeks ago - Pacira BioSciences to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 7 weeks ago - Pacira BioSciences Announces PCRX-201 Granted Regenerative Medicine Advance Therapy (RMAT) Designation for the Treatment of Osteoarthritis of the Knee - GlobeNewsWire
- 2 months ago - Pacira BioSciences to Participate in Fireside Chat at the Barclays 26th Annual Global Healthcare Conference - GlobeNewsWire
- 2 months ago - Pacira BioSciences Reports Fourth Quarter and Full-Year 2023 Financial Results - GlobeNewsWire
- 2 months ago - Pacira to Report 2023 Financial Results on Thursday February 29, 2024 - GlobeNewsWire
- 2 months ago - Pacira Announces Publication of Pivotal Study of EXPAREL as a Sciatic Nerve Block in the Popliteal Fossa for Patients After Bunionectomy - GlobeNewsWire
- 3 months ago - Pacira BioSciences Awarded Brand Pharmaceuticals Agreement With Premier, Inc. - GlobeNewsWire